Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

HESTER PHARM Gains 6%; BSE HEALTHCARE Index Down 0.3%
Fri, 8 Nov 12:19

HESTER PHARM Gains 6%; BSE HEALTHCARE Index Down 0.3%Image source: Sefa Ozel/www.istockphoto.com

HESTER PHARM share price has zoomed 6% and is presently trading at Rs 2,734.1.

Meanwhile, the BSE HEALTHCARE index is at 43,965.0 (down 0.3%).

Among the top gainers in the BSE HEALTHCARE index today are Abbott India (up 1.1%) and NARAYANA HRUDAYALAYA (up 1.0%).

ALEMBIC PHARMA (down 3.1%) and AJANTA PHARMA (down 2.3%) are among the top losers today.

Over the last one year, HESTER PHARM has moved up from Rs 1,698.3 to Rs 2,734.1, registering a gain of Rs 1,035.8 (up 61.0%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,089.2 to 43,965.0, registering a gain of 56.5% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 209.0%), SUVEN PHARMACEUTICALS (up 123.8%) and Glenmark Pharma (up 119.3%).

Don't Miss: Key Information for Long-term Investors

What About the Benchmark Indices?

The BSE Sensex is at 79,353.0 (down 0.2%).

The top losers among the BSE Sensex today are Asian Paints (down 2.6%) and ICICI Bank (down 1.9%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,119.5 (down 0.3%). Asian Paints and Coal India are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 64,958.7 to 79,353.0, registering a gain of 14,394.3 points (up 22.2%).

HESTER PHARM Financial Update...

HESTER PHARM net profit grew 198.4% YoY to Rs 74 million for the quarter ended September 2024, compared to a profit of Rs 25 million a year ago. Net sales rose 18.8% to Rs 837 million during the period as against Rs 705 million in July-September 2023.

For the year ended March 2024, HESTER PHARM reported 24.5% decrease in net profit to Rs 212 million compared to net profit of Rs 280 million during FY23. Revenue of the company grew 14.5% to Rs 3,045 million during FY24.

The current Price to earnings ratio of HESTER PHARM, based on rolling 12 month earnings, stands at 102.1.


Equitymaster requests your view! Post a comment on "HESTER PHARM Gains 6%; BSE HEALTHCARE Index Down 0.3%". Click here!